Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-3_05-md-01699/USCOURTS-cand-3_05-md-01699-230/pdf.json

Nature of Suit Code: 365
Nature of Suit: Personal Injury - Product Liability
Cause of Action: 28:1332 Diversity-Product Liability

---

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

-1- 

STIP. & ORDER RE: BRIEFING SCHEDULE AND PAGE LIMITS FOR AMENDED 

PURCHASE CLAIMS MASTER COMPLAINTS – M:05-CV-01699-CRB 

UNITED STATES DISTRICT COURT 

NORTHERN DISTRICT OF CALIFORNIA 

IN RE: BEXTRA AND CELEBREX 

MARKETING SALES PRACTICES AND 

PRODUCT LIABILITY LITIGATION 

CASE NO. M:05-CV-01699-CRB 

MDL No. 1699 

This Order Relates to: 

 ALL PURCHASE CLAIMS. 

STIPULATION AND ORDER 

REGARDING BRIEFING SCHEDULE 

AND PAGE LIMITS FOR AMENDED 

PURCHASE CLAIMS MASTER 

COMPLAINTS 

1. On August 16, 2006, this Court granted in part and denied in part the Pfizer 

Defendants’ motion to dismiss the Purchase Claims Master Celebrex Complaint. On August 24, 

2006, this Court granted in part and denied in part the Pfizer Defendants’ motion to dismiss the 

Purchase Claims Master Bextra Complaint. Certain claims in the Purchase Claims Master 

Complaints were dismissed with leave to amend. 

2. The Plaintiffs’ Steering Committee (“PSC”), on behalf of all plaintiffs 

asserting Purchase Claims, may file amended Purchase Claims Master Complaint(s) relating to 

Bextra and/or Celebrex on or before Friday, September 22, 2006. 

3. The Pfizer Defendants may file motion(s) to dismiss the amended Purchase 

Claims Master Complaint(s) by Friday, November 3, 2006. 

///// 

Case 3:05-md-01699-CRB Document 536 Filed 09/07/06 Page 1 of 2
1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

-2- 

STIP. & ORDER RE: BRIEFING SCHEDULE AND PAGE LIMITS FOR AMENDED 

PURCHASE CLAIMS MASTER COMPLAINTS – M:05-CV-01699-CRB 

4. The PSC shall file any opposition brief(s) to the Pfizer Defendants’ 

motion(s) to dismiss the Purchase Claims Master Complaint(s) by Friday, December 1, 2006. 

5. The Pfizer Defendants shall file any reply brief(s) in support of their 

motion(s) to dismiss the Purchase Claims Master Complaint(s) by Friday, December 15, 2006. 

6. By Friday, September 29, the parties shall meet and confer with respect to 

the page limits for briefing on the Purchase Claims Master Complaints. 

IT IS SO STIPULATED. 

Dated: August 31, 2006 LIEFF CABRASER HEIMANN & BERNSTEIN LLP 

By /s/ 

 ELIZABETH J. CABRASER 

Plaintiffs’ Liaison Counsel 

Dated: August 31, 2006 DLA PIPER RUDNICK GRAY CARY US LLP 

By /s/ 

 AMY W. SCHULMAN 

 Defendants’ Liaison Counsel 

PURSUANT TO STIPULATION, IT IS SO ORDERED. 

Dated: Sep. 7, 2006 /s/ 

HONORABLE CHARLES R. BREYER 

UNITED STATES DISTRICT JUDGE 

Case 3:05-md-01699-CRB Document 536 Filed 09/07/06 Page 2 of 2